Literature DB >> 11878889

Association of Vpu-binding protein with microtubules and Vpu-dependent redistribution of HIV-1 Gag protein.

M A Handley1, S Paddock, A Dall, A T Panganiban.   

Abstract

The efficient exit of HIV-1 particles from cells requires the action of the viral encoded protein Vpu. Vpu-binding protein (Ubp) is a cellular protein that interacts with both Vpu and the major structural component of the viral capsid (Gag) and appears to affect the efficiency of particle exit. Elucidation of the function of Ubp and characterization of the spatial distribution of Ubp may provide information pertinent to understanding the role of Ubp in virus replication. To investigate the subcellular location of Ubp, and to see whether Vpu affects the intracellular distribution of Gag, we carried out immunofluorescence localization in conjunction with confocal microscopy. Based on this analysis Ubp is present in both the nucleus and the cytoplasm. In the cytoplasm, Ubp appeared to be associated with microtubules as evidenced by cofluorescence with tubulin in the absence and in the presence of colchicine. However, cytoskeletal isolation and detergent extraction of cells resulted in association of Ubp with the soluble fractions, indicating that Ubp is not in tight association with microtubules. Moreover, flotation gradient analysis demonstrated that Ubp is cytoplasmic and not stably associated with the plasma membrane. Interestingly, expression of Vpu in cells resulted in redistribution of both Ubp and Gag to a location near the periphery of the cell. The effect of Vpu on both Ubp and Gag protein has implications for Vpu-mediated particle exit from cells. (C)2001 Elsevier Science.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11878889     DOI: 10.1006/viro.2001.1166

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  18 in total

1.  Recent Insights into HIV Accessory Proteins.

Authors:  Jenny L. Anderson; Thomas J. Hope
Journal:  Curr Infect Dis Rep       Date:  2003-10       Impact factor: 3.725

2.  Vpu and Tsg101 regulate intracellular targeting of the human immunodeficiency virus type 1 core protein precursor Pr55gag.

Authors:  Kirsi Harila; Ian Prior; Mathilda Sjöberg; Antti Salminen; Jorma Hinkula; Maarit Suomalainen
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

Review 3.  HIV Genome-Wide Protein Associations: a Review of 30 Years of Research.

Authors:  Guangdi Li; Erik De Clercq
Journal:  Microbiol Mol Biol Rev       Date:  2016-06-29       Impact factor: 11.056

4.  Dynamic fluorescent imaging of human immunodeficiency virus type 1 gag in live cells by biarsenical labeling.

Authors:  Lynnie Rudner; Sascha Nydegger; Lori V Coren; Kunio Nagashima; Markus Thali; David E Ott
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

5.  Expression and clinical role of small glutamine-rich tetratricopeptide repeat (TPR)-containing protein alpha (SGTA) as a novel cell cycle protein in NSCLC.

Authors:  Qun Xue; Liting Lv; Chunhua Wan; Buyou Chen; Mei Li; Tingting Ni; Yifei Liu; Yanhua Liu; Xia Cong; Yiqun Zhou; Runzhou Ni; Guoxin Mao
Journal:  J Cancer Res Clin Oncol       Date:  2013-07-16       Impact factor: 4.553

6.  The viral protein U (Vpu)-interacting host protein ATP6V0C down-regulates cell-surface expression of tetherin and thereby contributes to HIV-1 release.

Authors:  Abdul A Waheed; Maya Swiderski; Ali Khan; Ariana Gitzen; Ahlam Majadly; Eric O Freed
Journal:  J Biol Chem       Date:  2020-04-14       Impact factor: 5.157

7.  Evidence that productive human immunodeficiency virus type 1 assembly can occur in an intracellular compartment.

Authors:  Anjali Joshi; Sherimay D Ablan; Ferri Soheilian; Kunio Nagashima; Eric O Freed
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

8.  Expression, purification and preliminary crystallographic analysis of recombinant human small glutamine-rich tetratricopeptide-repeat protein.

Authors:  Sujit Dutta; Masayo Kotaka; Yee Joo Tan
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2008-06-07

9.  Targeting human immunodeficiency virus type 1 assembly, maturation and budding.

Authors:  Johanna Wapling; Seema Srivastava; Miranda Shehu-Xhilaga; Gilda Tachedjian
Journal:  Drug Target Insights       Date:  2007-07-20

10.  Evidence that Vpu modulates HIV-1 Gag-envelope interaction towards envelope incorporation and infectivity in a cell type dependent manner.

Authors:  Archana Gautam; Jayanta Bhattacharya
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.